Ambient

Molecular Formula : C15H23ClN2O3

Molecular Formula : C15H23ClN2O3

Molecular Formula : C15 H16 Cl N O2 S . Cl H

Molecular Formula : C15 H16 Cl N O2 S . Cl H

This Antibody recognizes both S1 tagged fusion proteins.

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP)

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP)

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP)

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

S100 calcium-binding protein A1 (S100A1) is a small calcium binding protein with EF-hand structures and belongs to the S100 family. S100 proteins include at least 25 members which are located as a cluster on human chromosome 1q21. S100A1 is found in the heart, skeletal muscle, brain, and kidney.S100A1 mainly resides on the sarcoplasmic reticulum, mitochondria and myofilaments. S100A1 may function in stimulation of Ca2+ induced Ca2+ release, inhibition of microtubule assembly, and inhibition of protein kinase C-mediated phosphorylation. Reduced expression of this protein has been implicated in cardiomyopathies.

S100 calcium-binding protein A1 (S100A1) is a small calcium binding protein with EF-hand structures and belongs to the S100 family. S100 proteins include at least 25 members which are located as a cluster on human chromosome 1q21. S100A1 is found in the heart, skeletal muscle, brain, and kidney.S100A1 mainly resides on the sarcoplasmic reticulum, mitochondria and myofilaments. S100A1 may function in stimulation of Ca2+ induced Ca2+ release, inhibition of microtubule assembly, and inhibition of protein kinase C-mediated phosphorylation. Reduced expression of this protein has been implicated in cardiomyopathies.

S100 calcium-binding protein A1 (S100A1) is a small calcium binding protein with EF-hand structures and belongs to the S100 family. S100 proteins include at least 25 members which are located as a cluster on human chromosome 1q21. S100A1 is found in the heart, skeletal muscle, brain, and kidney.S100A1 mainly resides on the sarcoplasmic reticulum, mitochondria and myofilaments. S100A1 may function in stimulation of Ca2+ induced Ca2+ release, inhibition of microtubule assembly, and inhibition of protein kinase C-mediated phosphorylation. Reduced expression of this protein has been implicated in cardiomyopathies.

Molecular Formula : C16H15NO7S

Molecular Formula : C16H15NO7S

Molecular Formula : C16H15NO7S

Molecular Formula : C23H32N2O2 . HCl

Molecular Formula : C23H32N2O2 . HCl

Molecular Formula : C23H32N2O2 . HCl

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Molecular Formula : C10 H16

Molecular Formula : C10 H16

Molecular Formula : C10 H18 O

Molecular Formula : C10 H18 O

Molecular Formula : C10 H18 O

Sabouraud Dextrose Agar can be used for the isolation, identification and maintainance of pathogenic and saprophytic fungi. It is suited for the cultivation of yeasts, molds and aciduric microorganisms.

Molecular Formula : C7 H5 N O3 S

Molecular Formula : C7 H5 N O3 S

Molecular Formula : C7 H5 N O3 S

Molecular Formula : 4 C7 H4 N O3 S . 2 Ca . 7 H2 O

Molecular Formula : 4 C7 H4 N O3 S . 2 Ca . 7 H2 O

Saccharin Calcium, Crystal, USP

Molecular Formula : C11 H11 N O5 S